SPECT imaging of nicotinic acetylcholine receptors in nonsmoking heavy alcohol drinking individuals
- PMID: 20074869
- PMCID: PMC2871672
- DOI: 10.1016/j.drugalcdep.2009.12.006
SPECT imaging of nicotinic acetylcholine receptors in nonsmoking heavy alcohol drinking individuals
Abstract
Background: The high rate of comorbidity of tobacco smoking with alcohol drinking suggests common neural substrates mediate the two addictive disorders. The beta(2)*-containing nicotinic acetylcholine receptor (beta(2)*-nAChR) has recently emerged as a prime candidate because some alpha and beta subunit genes have been linked to alcohol consumption and alcohol use behaviors. We hypothesized that beta(2)*-nAChR availability would be altered by alcohol in heavy drinking nonsmokers.
Methods: Eleven heavy drinking (mean age 39.6+/-12.1 years) and 11 age and sex-matched control (mean age 40.8+/-14.1 years) nonsmokers were imaged using [(123)I]5-IA-85380 ([(123)I]5-IA) single photon emission computed tomography (SPECT). Heavy alcohol drinkers drank varied amounts of alcohol (70-428/month) to facilitate exploratory linear analyses of the possible effects of alcohol.
Results: Heavy drinkers consumed on average 9.1+/-7.3 drinks/occasion; whereas controls drank 1.2+/-0.9 drinks/occasion. Heavy drinkers were imaged 2.0+/-1.6 days after last alcoholic beverage. Overall, there were no significant differences in beta(2)*-nAChR availability between the heavy drinking and control nonsmokers. Exploratory analyses of other factors that may be uniquely regulated by alcohol suggested no effects of age, number of alcohol drinks, years drinking, severity of drinking, craving or withdrawal.
Conclusions: These preliminary analyses do not suggest a decrease in receptor availability in heavy drinking nonsmokers as compared to control nonsmokers. However, a larger study is warranted to explore effects of heavy alcohol drinking on other variables, such as sex, smoking, and genetic make up.
Published by Elsevier Ireland Ltd.
Figures

Similar articles
-
Sex differences in availability of β2*-nicotinic acetylcholine receptors in recently abstinent tobacco smokers.Arch Gen Psychiatry. 2012 Apr;69(4):418-27. doi: 10.1001/archgenpsychiatry.2011.1465. Arch Gen Psychiatry. 2012. PMID: 22474108 Free PMC article.
-
beta2-Nicotinic acetylcholine receptor availability during acute and prolonged abstinence from tobacco smoking.Arch Gen Psychiatry. 2009 Jun;66(6):666-76. doi: 10.1001/archgenpsychiatry.2009.41. Arch Gen Psychiatry. 2009. PMID: 19487632 Free PMC article.
-
123I-5-IA-85380 SPECT imaging of nicotinic acetylcholine receptor availability in nonsmokers: effects of sex and menstrual phase.J Nucl Med. 2007 Oct;48(10):1633-40. doi: 10.2967/jnumed.107.042317. Epub 2007 Sep 14. J Nucl Med. 2007. PMID: 17873128
-
Central in vivo nicotinic acetylcholine receptor imaging agents for positron emission tomography (PET) and single photon emission computed tomography (SPECT).Biol Pharm Bull. 2009 Mar;32(3):337-40. doi: 10.1248/bpb.32.337. Biol Pharm Bull. 2009. PMID: 19252274 Review.
-
The role of nicotinic acetylcholine receptors in alcohol-related behaviors.Brain Res Bull. 2020 Oct;163:135-142. doi: 10.1016/j.brainresbull.2020.07.017. Epub 2020 Jul 22. Brain Res Bull. 2020. PMID: 32707263 Free PMC article. Review.
Cited by
-
Imaging of cerebral α4β2* nicotinic acetylcholine receptors with (-)-[(18)F]Flubatine PET: Implementation of bolus plus constant infusion and sensitivity to acetylcholine in human brain.Neuroimage. 2016 Nov 1;141:71-80. doi: 10.1016/j.neuroimage.2016.07.026. Epub 2016 Jul 15. Neuroimage. 2016. PMID: 27426839 Free PMC article.
-
Varenicline potentiates alcohol-induced negative subjective responses and offsets impaired eye movements.Alcohol Clin Exp Res. 2012 May;36(5):906-14. doi: 10.1111/j.1530-0277.2011.01675.x. Epub 2012 Feb 16. Alcohol Clin Exp Res. 2012. PMID: 22339626 Free PMC article.
-
Changes in the α4β2* nicotinic acetylcholine system during chronic controlled alcohol exposure in nonhuman primates.Drug Alcohol Depend. 2014 May 1;138:216-9. doi: 10.1016/j.drugalcdep.2014.01.027. Epub 2014 Feb 15. Drug Alcohol Depend. 2014. PMID: 24602361 Free PMC article.
-
In vivo evidence for β2 nicotinic acetylcholine receptor subunit upregulation in smokers as compared with nonsmokers with schizophrenia.Biol Psychiatry. 2014 Sep 15;76(6):495-502. doi: 10.1016/j.biopsych.2013.11.001. Epub 2013 Nov 13. Biol Psychiatry. 2014. PMID: 24360979 Free PMC article.
-
Rewarding, stimulant, and sedative alcohol responses and relationship to future binge drinking.Arch Gen Psychiatry. 2011 Apr;68(4):389-99. doi: 10.1001/archgenpsychiatry.2011.26. Arch Gen Psychiatry. 2011. PMID: 21464363 Free PMC article. Clinical Trial.
References
-
- ARENDT T, BIGL B, ARENDT A, TENNESTEDT A. Loss of neurons in the nucleus basalis of Meynert in Alzheimer's disease, paralysis agitans, and Korsakoff's Disease. Acta Neuropathol. 1983;61:101–108. - PubMed
-
- BERACOCHEA D, DURKIN T, JAFFARD R. On the involvement of the central cholinergic system in memory deficits induced by long-term ethanol consumption in mice. Pharmacol. Biochem. Behav. 1986;24:519–24. - PubMed
-
- BLOMQVIST O, HERNANDEZ-AVILA C, KIRK JV, ROSE J, KRANZLER H. Mecamylamine Modifies the Pharmacokinetics and Reinforcing Effects of Alcohol. ALCOHOLISM: CLINICAL AND EXPERIMENTAL RESEARCH. 2002;26:326–331. - PubMed
-
- BUTT C, HUTTON S, STITZEL J, BALOGH S, OWENS J, COLLINS A. A polymorphism in the α4 nicotinic receptor gene (Chrna4) modulates enhancement of nicotinic receptor function by ethanol. Alcoholism, Clin and Exp Res. 2003;27:733–742. - PubMed
-
- CHI H, WIT HD. Mecamylamine Attenuates the Subjective Stimulant-Like Effects of Alcohol in Social Drinkers. ALCOHOLISM: CLINICAL AND EXPERIMENTAL RESEARCH. 2003;27:780–86. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical